EMAIL THIS PAGE TO A FRIEND

Human molecular genetics

Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis.


PMID 25859013

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder primarily affecting motor neurons. Mutations in optineurin cause a small proportion of familial ALS cases, and wild-type (WT) optineurin is misfolded and forms inclusions in sporadic ALS patient motor neurons. However, it is unknown how optineurin mutation or misfolding leads to ALS. Optineurin acts an adaptor protein connecting the molecular motor myosin VI to secretory vesicles and autophagosomes. Here, we demonstrate that ALS-linked mutations p.Q398X and p.E478G disrupt the association of optineurin with myosin VI, leading to an abnormal diffuse cytoplasmic distribution, inhibition of secretory protein trafficking, endoplasmic reticulum (ER) stress and Golgi fragmentation in motor neuron-like NSC-34 cells. We also provide further insight into the role of optineurin as an autophagy receptor. WT optineurin associated with lysosomes and promoted autophagosome fusion to lysosomes in neuronal cells, implying that it mediates trafficking of lysosomes during autophagy in association with myosin VI. However, either expression of ALS mutant optineurin or small interfering RNA-mediated knockdown of endogenous optineurin blocked lysosome fusion to autophagosomes, resulting in autophagosome accumulation. Together these results indicate that ALS-linked mutations in optineurin disrupt myosin VI-mediated intracellular trafficking processes. In addition, in control human patient tissues, optineurin displayed its normal vesicular localization, but in sporadic ALS patient tissues, vesicles were present in a significantly decreased proportion of motor neurons. Optineurin binding to myosin VI was also decreased in tissue lysates from sporadic ALS spinal cords. This study therefore links several previously described pathological mechanisms in ALS, including defects in autophagy, fragmentation of the Golgi and induction of ER stress, to disruption of optineurin function. These findings also indicate that optineurin-myosin VI dysfunction is a common feature of both sporadic and familial ALS.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4503258
Anti-Calnexin, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB2501291
Anti-CANX antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405706
Anti-DDIT3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1412027
ANTI-ERN1 antibody produced in mouse, clone 1F12, purified immunoglobulin, buffered aqueous solution
SAB1412028
ANTI-ERN1 antibody produced in mouse, clone 5F3, purified immunoglobulin, buffered aqueous solution
SAB1412029
ANTI-ERN1 antibody produced in mouse, clone 6G11, purified immunoglobulin, buffered aqueous solution
SAB1412341
ANTI-ERN1 antibody produced in mouse, clone 4E1, purified immunoglobulin, buffered aqueous solution
SAB1412645
ANTI-ERN1 antibody produced in mouse, clone 4D12, purified immunoglobulin, buffered aqueous solution
HPA027730 Anti-ERN1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
G6916 Anti-GADD153 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4500632
Anti-GADD153 antibody produced in rabbit, affinity isolated antibody
G7295
Anti-GM130 (C-terminal) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1405886
Anti-GOLGA2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA021178
Anti-GOLGA2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA021230
Anti-GOLGA2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
HPA021799
Anti-GOLGA2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab3
PRS3655
Anti-IRE1P (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3657
Anti-IRE1P (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3659
Anti-IRE1P (ab3) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3627
Anti-LAMP-2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
L0668
Anti-LAMP2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701987
Anti-LAMP2 antibody produced in rabbit
SAB2702058
Anti-LAMP2 antibody produced in rabbit
HPA029100
Anti-LAMP2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1307259
ANTI-MYO6 (C-TERM R1181) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
M5187
Anti-Myosin VI (KA-15) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2101685
Anti-OPTN (ab2) antibody produced in rabbit, affinity isolated antibody
SAB2101686
Anti-OPTN (ab3) antibody produced in rabbit, affinity isolated antibody
SAB1406930
Anti-OPTN antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA003279
Anti-OPTN antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution